20
Participants
Start Date
August 21, 2013
Primary Completion Date
November 7, 2018
Study Completion Date
July 16, 2022
Dendritic Cell Vaccine
Between 1.2 to 12 million DC per dose administered once a week via intradermal injection for 4 weeks.
Tumor Lysate
Post-DC Vaccine therapy. Up to 1.5 mg of Lysate of tumor per dose administered via intradermal injection at intervals defined by study protocol.
Imiquimod
5% topical cream applied to vaccine site before and after administrations of DC vaccine or lysate
Leukapheresis
Baseline, post-surgery blood draw via catheter to obtain peripheral blood mononuclear cells (PBMCs) from which Dendritic cells will be obtained.
University of Miami, Miami
Macarena De La Fuente, MD
OTHER